Logo image of ALREW.PA

REWORLD (ALREW.PA) Stock Fundamental Analysis

EPA:ALREW - FR0010820274 - Common Stock

1.712 EUR
-0.01 (-0.47%)
Last: 9/3/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ALREW. ALREW was compared to 62 industry peers in the Media industry. ALREW has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on ALREW.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year ALREW was profitable.
In the past year ALREW had a positive cash flow from operations.
In the past 5 years ALREW has always been profitable.
In the past 5 years ALREW always reported a positive cash flow from operatings.
ALREW.PA Yearly Net Income VS EBIT VS OCF VS FCFALREW.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

ALREW's Return On Assets of 3.65% is fine compared to the rest of the industry. ALREW outperforms 69.35% of its industry peers.
ALREW has a better Return On Equity (10.95%) than 70.97% of its industry peers.
ALREW's Return On Invested Capital of 8.44% is fine compared to the rest of the industry. ALREW outperforms 79.03% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALREW is above the industry average of 7.82%.
Industry RankSector Rank
ROA 3.65%
ROE 10.95%
ROIC 8.44%
ROA(3y)4.63%
ROA(5y)4.84%
ROE(3y)15.78%
ROE(5y)17.69%
ROIC(3y)10.02%
ROIC(5y)11.09%
ALREW.PA Yearly ROA, ROE, ROICALREW.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

ALREW's Profit Margin of 4.36% is fine compared to the rest of the industry. ALREW outperforms 62.90% of its industry peers.
ALREW's Profit Margin has declined in the last couple of years.
ALREW has a better Operating Margin (8.81%) than 66.13% of its industry peers.
ALREW's Operating Margin has declined in the last couple of years.
ALREW has a Gross Margin (61.10%) which is in line with its industry peers.
ALREW's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.81%
PM (TTM) 4.36%
GM 61.1%
OM growth 3Y-11.07%
OM growth 5Y-15.59%
PM growth 3Y-19.13%
PM growth 5Y-12.76%
GM growth 3Y-3.09%
GM growth 5Y19.36%
ALREW.PA Yearly Profit, Operating, Gross MarginsALREW.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

ALREW has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for ALREW remains at a similar level compared to 1 year ago.
The number of shares outstanding for ALREW has been increased compared to 5 years ago.
Compared to 1 year ago, ALREW has an improved debt to assets ratio.
ALREW.PA Yearly Shares OutstandingALREW.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ALREW.PA Yearly Total Debt VS Total AssetsALREW.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 1.73, we must say that ALREW is in the distress zone and has some risk of bankruptcy.
ALREW has a Altman-Z score (1.73) which is comparable to the rest of the industry.
The Debt to FCF ratio of ALREW is 10.26, which is on the high side as it means it would take ALREW, 10.26 years of fcf income to pay off all of its debts.
ALREW has a Debt to FCF ratio (10.26) which is comparable to the rest of the industry.
ALREW has a Debt/Equity ratio of 0.87. This is a neutral value indicating ALREW is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.87, ALREW is in line with its industry, outperforming 51.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 10.26
Altman-Z 1.73
ROIC/WACC1.52
WACC5.55%
ALREW.PA Yearly LT Debt VS Equity VS FCFALREW.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ALREW has a Current Ratio of 1.52. This is a normal value and indicates that ALREW is financially healthy and should not expect problems in meeting its short term obligations.
ALREW has a better Current ratio (1.52) than 79.03% of its industry peers.
ALREW has a Quick Ratio of 1.50. This is a normal value and indicates that ALREW is financially healthy and should not expect problems in meeting its short term obligations.
ALREW has a better Quick ratio (1.50) than 79.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.5
ALREW.PA Yearly Current Assets VS Current LiabilitesALREW.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

The earnings per share for ALREW have decreased by -8.61% in the last year.
The Earnings Per Share has been decreasing by -6.09% on average over the past years.
ALREW shows a decrease in Revenue. In the last year, the revenue decreased by -2.65%.
The Revenue has been growing by 12.68% on average over the past years. This is quite good.
EPS 1Y (TTM)-8.61%
EPS 3Y-18.34%
EPS 5Y-6.09%
EPS Q2Q%17.2%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y4.41%
Revenue growth 5Y12.68%
Sales Q2Q%-4.34%

3.2 Future

ALREW is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.11% yearly.
Based on estimates for the next years, ALREW will show a small growth in Revenue. The Revenue will grow by 1.18% on average per year.
EPS Next Y6.06%
EPS Next 2Y12.48%
EPS Next 3Y12.11%
EPS Next 5YN/A
Revenue Next Year-0.83%
Revenue Next 2Y0.62%
Revenue Next 3Y1.18%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALREW.PA Yearly Revenue VS EstimatesALREW.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALREW.PA Yearly EPS VS EstimatesALREW.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 0.6

9

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.76, which indicates a rather cheap valuation of ALREW.
Based on the Price/Earnings ratio, ALREW is valued cheaper than 95.16% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALREW to the average of the S&P500 Index (26.84), we can say ALREW is valued rather cheaply.
With a Price/Forward Earnings ratio of 3.56, the valuation of ALREW can be described as very cheap.
Based on the Price/Forward Earnings ratio, ALREW is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.48. ALREW is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.76
Fwd PE 3.56
ALREW.PA Price Earnings VS Forward Price EarningsALREW.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALREW indicates a somewhat cheap valuation: ALREW is cheaper than 79.03% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ALREW is valued cheaply inside the industry as 82.26% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.49
EV/EBITDA 3.62
ALREW.PA Per share dataALREW.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALREW has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ALREW's earnings are expected to grow with 12.11% in the coming years.
PEG (NY)0.78
PEG (5Y)N/A
EPS Next 2Y12.48%
EPS Next 3Y12.11%

2

5. Dividend

5.1 Amount

ALREW has a Yearly Dividend Yield of 1.08%.
Compared to an average industry Dividend Yield of 6.03, ALREW has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, ALREW's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.08%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALREW.PA Yearly Dividends per shareALREW.PA Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.01 0.02

5.3 Sustainability

DPN/A
EPS Next 2Y12.48%
EPS Next 3Y12.11%
ALREW.PA Yearly Income VS Free CF VS DividendALREW.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

REWORLD

EPA:ALREW (9/3/2025, 7:00:00 PM)

1.712

-0.01 (-0.47%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)07-08 2025-07-08
Earnings (Next)02-10 2026-02-10
Inst Owners14.74%
Inst Owner ChangeN/A
Ins Owners23.34%
Ins Owner ChangeN/A
Market Cap99.36M
Analysts89.09
Price Target4.62 (169.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.08%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-8.5%
EPS NY rev (3m)-8.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.03%
Revenue NY rev (3m)-1.59%
Valuation
Industry RankSector Rank
PE 4.76
Fwd PE 3.56
P/S 0.19
P/FCF 5.49
P/OCF 3.73
P/B 0.47
P/tB N/A
EV/EBITDA 3.62
EPS(TTM)0.36
EY21.03%
EPS(NY)0.48
Fwd EY28.08%
FCF(TTM)0.31
FCFY18.22%
OCF(TTM)0.46
OCFY26.83%
SpS9.21
BVpS3.67
TBVpS-2.37
PEG (NY)0.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.65%
ROE 10.95%
ROCE 10.14%
ROIC 8.44%
ROICexc 10.38%
ROICexgc 143.53%
OM 8.81%
PM (TTM) 4.36%
GM 61.1%
FCFM 3.39%
ROA(3y)4.63%
ROA(5y)4.84%
ROE(3y)15.78%
ROE(5y)17.69%
ROIC(3y)10.02%
ROIC(5y)11.09%
ROICexc(3y)12.89%
ROICexc(5y)19.45%
ROICexgc(3y)259.8%
ROICexgc(5y)N/A
ROCE(3y)12.04%
ROCE(5y)13.33%
ROICexcg growth 3Y-90.01%
ROICexcg growth 5YN/A
ROICexc growth 3Y-21.99%
ROICexc growth 5Y-22.15%
OM growth 3Y-11.07%
OM growth 5Y-15.59%
PM growth 3Y-19.13%
PM growth 5Y-12.76%
GM growth 3Y-3.09%
GM growth 5Y19.36%
F-Score7
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 10.26
Debt/EBITDA 3.39
Cap/Depr 111.17%
Cap/Sales 1.6%
Interest Coverage 250
Cash Conversion 48.64%
Profit Quality 77.74%
Current Ratio 1.52
Quick Ratio 1.5
Altman-Z 1.73
F-Score7
WACC5.55%
ROIC/WACC1.52
Cap/Depr(3y)78.11%
Cap/Depr(5y)67.07%
Cap/Sales(3y)1.5%
Cap/Sales(5y)1.51%
Profit Quality(3y)60.69%
Profit Quality(5y)85.44%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.61%
EPS 3Y-18.34%
EPS 5Y-6.09%
EPS Q2Q%17.2%
EPS Next Y6.06%
EPS Next 2Y12.48%
EPS Next 3Y12.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y4.41%
Revenue growth 5Y12.68%
Sales Q2Q%-4.34%
Revenue Next Year-0.83%
Revenue Next 2Y0.62%
Revenue Next 3Y1.18%
Revenue Next 5YN/A
EBIT growth 1Y-16.61%
EBIT growth 3Y-7.15%
EBIT growth 5Y-4.89%
EBIT Next Year22.35%
EBIT Next 3Y12.34%
EBIT Next 5YN/A
FCF growth 1Y59.16%
FCF growth 3Y-14.06%
FCF growth 5YN/A
OCF growth 1Y23.54%
OCF growth 3Y-8.92%
OCF growth 5YN/A